ENTERO HEALTHCARE SOLUTIONS
|
ENTERO HEALTHCARE SOLUTIONS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 21.79 | 8.99 | -28.11 | -77.71 | -1,553.70 |
| CEPS(Rs) | 31.75 | 14.90 | 31.94 | -25.16 | 92.20 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 395.31 | 376.21 | -166.80 | -150.52 | -3,174.60 |
| Tax Rate(%) | 22.56 | -11.94 | -201.08 | -48.60 | -41.67 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 3.37 | 2.85 | 1.94 | 0.97 | 1.21 |
| EBIT Margin(%) | 3.54 | 2.58 | 1.37 | 0.36 | 0.52 |
| Pre Tax Margin(%) | 2.72 | 0.91 | -0.11 | -0.79 | -0.61 |
| PAT Margin (%) | 2.11 | 1.01 | -0.34 | -1.17 | -0.86 |
| Cash Profit Margin (%) | 2.71 | 1.65 | 0.40 | -0.38 | 0.05 |
| Performance Ratios | |||||
| ROA(%) | 4.29 | 2.19 | -0.91 | -3.01 | -1.84 |
| ROE(%) | 6.40 | 5.08 | - | - | - |
| ROCE(%) | 9.16 | 7.02 | 4.99 | 1.24 | 1.47 |
| Asset Turnover(x) | 2.03 | 2.16 | 2.71 | 2.58 | 2.14 |
| Sales/Fixed Asset(x) | 9.53 | 10.87 | 10.16 | 9.53 | 8.15 |
| Working Capital/Sales(x) | 4.14 | 2.78 | 8.27 | 6.48 | 5.18 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.10 | 0.09 | 0.10 | 0.10 | 0.12 |
| Receivable days | 51.78 | 52.59 | 49.19 | 44.63 | 49.66 |
| Inventory Days | 38.71 | 35.49 | 36.04 | 40.09 | 50.03 |
| Payable days | 24.83 | 22.51 | 21.08 | 18.67 | 21.55 |
| Valuation Parameters | |||||
| PER(x) | 52.15 | 109.53 | - | - | - |
| PCE(x) | 35.80 | 66.09 | - | - | - |
| Price/Book(x) | 2.88 | 2.62 | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.98 | 0.93 | 0.28 | 0.32 | 0.32 |
| EV/Core EBITDA(x) | 23.61 | 29.04 | 13.45 | 27.75 | 22.61 |
| EV/EBIT(x) | 27.63 | 36.21 | 20.65 | 87.54 | 62.62 |
| EV/CE(x) | 2.46 | 1.92 | 0.96 | 0.71 | 0.69 |
| M Cap / Sales | 0.97 | 1.09 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 29.92 | 18.85 | 30.85 | 41.71 | - |
| Core EBITDA Growth(%) | 67.16 | 81.61 | 140.38 | 13.52 | - |
| EBIT Growth(%) | 78.15 | 123.56 | 393.99 | -0.36 | - |
| PAT Growth(%) | 169.94 | 458.42 | 62.28 | -91.74 | - |
| EPS Growth(%) | 142.37 | 131.99 | 63.83 | 95.00 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.17 | 0.17 | 0.63 | 0.51 | 0.29 |
| Current Ratio(x) | 2.46 | 3.34 | 1.64 | 1.84 | 2.19 |
| Quick Ratio(x) | 1.68 | 2.64 | 1.09 | 1.17 | 1.35 |
| Interest Cover(x) | 4.33 | 1.54 | 0.92 | 0.32 | 0.46 |
| Total Debt/Mcap(x) | 0.06 | 0.06 | - | - | - |
Compare Financial Ratios of peers of ENTERO HEALTHCARE SOLUTIONS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ENTERO HEALTHCARE SOLUTIONS | ₹4,744.5 Cr | -2.4% | -10.2% | -17.6% | Stock Analytics | |
| ADANI ENTERPRISES | ₹302,430.0 Cr | 11.3% | 15% | -10.6% | Stock Analytics | |
| REDINGTON | ₹21,424.5 Cr | -2.5% | 17.2% | 52% | Stock Analytics | |
| MMTC | ₹10,242.0 Cr | 6.1% | 9.4% | -21.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,041.7 Cr | -4.1% | -7.2% | 72.2% | Stock Analytics | |
| HONASA CONSUMER | ₹9,762.7 Cr | -0.7% | 0.3% | -36.3% | Stock Analytics | |
ENTERO HEALTHCARE SOLUTIONS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ENTERO HEALTHCARE SOLUTIONS | -2.4% |
-10.2% |
-17.6% |
| SENSEX | -1.2% |
0.5% |
-1.8% |
You may also like the below Video Courses
